Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 2/20 | 0.33 |
| ▸ | PDE4D | Q08499 | 6/20 | 0.32 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.30 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.30 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.30 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.30 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.30 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3150477 | 0.86 | KDM4E (0.40) | MAPTKDM4EMEN1LMNAOPRK1 | |
| SCHEMBL3150622 | 0.85 | KDM4E (0.41) | MAPTKDM4EMEN1LMNAOPRK1 | |
| SCHEMBL440029 | 0.84 | GABRA1 (0.35) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL3150471 | 0.83 | ESR1 (0.35) | PDE4D | |
| SCHEMBL14822802 | 0.81 | CYP1A1 (0.33) | GABRA1GABRG2GABRB3GABRA5GABRA3 | |
| SCHEMBL3136635 | 0.80 | MAPT (0.47) | MAPTKDM4EMEN1LMNAOPRK1 | |
| SCHEMBL3150217 | 0.80 | MAPT (0.47) | MAPTKDM4EMEN1LMNAOPRK1 | |
| SCHEMBL3155270 | 0.80 | MAPT (0.47) | MAPTKDM4EMEN1LMNAOPRK1 | |
| SCHEMBL3146256 | 0.79 | MAPT (0.56) | MAPTKDM4EMEN1LMNAOPRK1 | |
| SCHEMBL6005451 | 0.77 | PDK2 (0.37) | MAPTKDM4EMEN1LMNAOPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8218937-B2 | Optical film, image display device, diethynylfluorene, and polymer thereof | NITTO DENKO CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100003490-A1 | OPTICAL FILM, IMAGE DISPLAY DEVICE, DIETHYNYLFLUORENE, AND POLYMER THEREOF | NITTO DENKO CORPORATION (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100003490-A1 | OPTICAL FILM, IMAGE DISPLAY DEVICE, DIETHYNYLFLUORENE, AND POLYMER THEREOF | PDCD2L, FMNL1, MACF1 | MAPT 250/4885KDM4E 1125/4885MEN1 1959/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.